08/15/2025
7:41 AM | Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2025
8:37 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2025
4:29 PM | Aquestive Therapeutics (Filer)
| Form 424B5 | |
08/14/2025
5:26 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2025
6:54 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2025
6:48 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2025
12:57 PM | Aquestive Therapeutics (Issuer)
Taglietti Marco (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
12:58 PM | Aquestive Therapeutics (Issuer)
Cochran John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
12:59 PM | Aquestive Therapeutics (Issuer)
Jenkins Abigail L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
12:59 PM | Aquestive Therapeutics (Issuer)
MORRIS TIMOTHY E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
12:59 PM | Aquestive Therapeutics (Issuer)
Krop Julie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for AQST and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aquestive Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/12/2025
1:13 PM | Aquestive Therapeutics (Issuer)
BROWN GREGORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:21 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2025
1:12 PM | Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2025
8:10 AM | Aquestive Therapeutics (Issuer)
Cioffi Melina (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/25/2025
3:31 PM | Aquestive Therapeutics (Filer)
| Form DEF 14A | |
04/25/2025
3:33 PM | Aquestive Therapeutics (Filer)
| Form DEFA14A | |
04/25/2025
3:34 PM | Aquestive Therapeutics (Filer)
| Form ARS | |
04/01/2025
7:26 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2025
4:47 PM | Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
4:47 PM | Aquestive Therapeutics (Issuer)
Boyd Peter E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
4:47 PM | Aquestive Therapeutics (Issuer)
BRAENDER LORI J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
4:48 PM | Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
4:48 PM | Aquestive Therapeutics (Issuer)
Kraus Carl N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
4:48 PM | Aquestive Therapeutics (Issuer)
TOTH A ERNEST JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
4:48 PM | Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
4:49 PM | Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:10 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
3:29 PM | Aquestive Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
5:12 PM | Aquestive Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/13/2025
10:38 AM | Aquestive Therapeutics (Subject)
BRATTON DOUGLAS K (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025
6:22 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
3:51 PM | Aquestive Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/13/2025
6:07 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2024
7:02 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2024
7:08 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
3:40 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
3:42 PM | Aquestive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/25/2024
7:05 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
7:06 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
5:06 PM | Aquestive Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
Silver’s Still Under $35… For Now. (Ad) Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end.
With supply shrinking and demand surging from AI, EVs, and defense tech, this could be the most overlooked setup of 2025. Most investors haven’t caught on yet. Get the Silver Forecast before the breakout hits front-page news |
10/16/2024
4:16 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
1:14 PM | Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
| Form 4/A | |
10/02/2024
1:15 PM | Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
| Form 4/A | |
10/02/2024
1:15 PM | Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
| Form 4/A | |
10/02/2024
1:16 PM | Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
| Form 4/A | |
09/27/2024
7:46 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
7:56 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access